Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance
Tweet
Share
E-mail
Get Alerts THC Hot Sheet
Price: $256.44 --0%
EPS Growth %: +25.1%
Financial Fact:
Litigation and investigation costs: 4M
Today's EPS Names:
LGCY, UXIN, SCHL, More
EPS Growth %: +25.1%
Financial Fact:
Litigation and investigation costs: 4M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $2.31, $0.41 better than the analyst estimate of $1.90. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.99 billion.
GUIDANCE:
Tenet Healthcare sees Q3 2024 EPS of $2.16-$2.58, versus the consensus of $1.67. Tenet Healthcare sees Q3 2024 revenue of $5-5.1 billion, versus the consensus of $4.889 billion.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lucid Capital Markets Starts Turn Therapeutics (TTRX) at Buy
- NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
- Increasing unusual call option volume: GFL ABUS JETS RNG ERIC SABR U QSR DC FSLY
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
